Prolonged remission of Epstein-Barr virus associated lymphoma secondary to T cell-depleted bone marrow transplantation

M. P.A. Lyttelton, P. J. Browett, M. K. Brenner, J. D. Norton, J. L. Kolman, J. McGee O'D., S. Hamilton-Dutoit, A. V. Hoffbrand, H. G. Prentice

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

High grade non-Hodgkin's lymphoma developed 42 days after allogeneic T cell-depleted bone marrow transplantation (BMT) for idiopathic aplastic anaemia. DNA hybridization studies confirmed clonality and incorporation of Epstein-Barr virus (EBV) genome. Prolonged remission followed low dose chemotherapy, local radiotherapy and early withdrawal of cyclosporin.

Original languageEnglish (US)
Pages (from-to)641-646
Number of pages6
JournalBone Marrow Transplantation
Volume3
Issue number6
StatePublished - 1988

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Fingerprint Dive into the research topics of 'Prolonged remission of Epstein-Barr virus associated lymphoma secondary to T cell-depleted bone marrow transplantation'. Together they form a unique fingerprint.

Cite this